Alyeska Investment Group
NPTN

Alyeska Investment Group’s NEOPHOTONICS CORP NPTN Stock Holding History

Alyeska Investment Group’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-358,730
Closed -$3.66M – 863
2021
Q2 		$3.66M Buy
+358,730
New +$3.79M 0.04% 403
2019
Q3 		– Sell
-207,818
Closed -$869K – 539
2019
Q2 		$869K Buy
+207,818
New +$1.1M 0.01% 374
2018
Q2 		– Sell
-320,513
Closed -$2.2M – 555
2018
Q1 		$2.2M Buy
+320,513
New +$2.04M 0.02% 342
2017
Q3 		– Sell
-1,762,265
Closed -$13.6M – 563
2017
Q2 		$13.6M Buy
+1,762,265
New +$14.9M 0.11% 216
2017
Q1 		– Sell
-339,815
Closed -$3.67M – 577
2016
Q4 		$3.67M Buy
+339,815
New +$4.53M 0.03% 351

Other funds holding NPTN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group's NPTN Position: Q3 2021 in Review

Alyeska Investment Group sold out of NEOPHOTONICS CORP (NPTN) in Q3 2021, closing a stake of 358,730 shares — an estimated $3.66M sold.

Alyeska Investment Group first reported a position in NPTN in Q4 2016 and held it in 5 quarters. The position peaked at $13.6M in Q2 2017. 124 funds tracked by Wall St. Rank hold NPTN as of Q3 2021.

  • Alyeska Investment Group reported no remaining NEOPHOTONICS CORP position as of Q3 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 358,730 NEOPHOTONICS CORP shares in Q3 2021, an estimated $3.66M.
  • Alyeska Investment Group first reported a position in NEOPHOTONICS CORP in Q4 2016 and held it in 5 quarters.
  • Alyeska Investment Group's NEOPHOTONICS CORP position peaked at $13.6M in Q2 2017.
  • 124 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2021.

Based on Alyeska Investment Group's 13F filing for Q3 2021, filed 15 Nov 2021.